The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance

被引：0
|
作者：
Wang, Qing [1 ]
Yang, Hsin-Sheng [1 ,2 ]
机构：
[1] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA
[2] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA
来源：
PHARMACEUTICALS | 2024年 / 17卷 / 10期
关键词：
eIF4A; mTORC2-Akt pathway; beta-catenin pathway; JNK pathway; paclitaxel; doxorubicin; fluorouracil; platinum-containing drug; IGF1R/IR inhibitor; SUPPRESSOR PROTEIN PDCD4; NF-KAPPA-B; TRANSFORMATION SUPPRESSOR; CANCER CELLS; DEPENDENT TRANSCRIPTION; EUKARYOTIC TRANSLATION; DOXORUBICIN RESISTANCE; MOLECULAR-MECHANISMS; ARGININE METHYLATION; MAMMALIAN TARGET;
D O I：
10.3390/ph17101396
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Programmed cell death 4 (Pdcd4) is a tumor suppressor, which has been demonstrated to efficiently suppress tumorigenesis. Biochemically, Pdcd4 binds with translation initiation factor 4A and represses protein translation. Beyond its role in tumor suppression, growing evidence suggests that Pdcd4 enhances the chemosensitivity of several anticancer drugs. To date, numerous translational targets of Pdcd4 have been identified. These targets govern important signal transduction pathways, and their attenuation may improve chemosensitivity or overcome drug resistance. This review will discuss the signal transduction pathways regulated by Pdcd4 and the potential mechanisms through which Pdcd4 enhances chemosensitivity or counteracts drug resistance.
引用
收藏
页数：12
相关论文
共 50 条
  • [31] Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation
    P Singh
    L Wedeken
    L C Waters
    M D Carr
    K-H Klempnauer
    Oncogene, 2011, 30 : 4864 - 4873
  • [32] Identification of the translational targets of tumor suppressor Pdcd4
    Yoshikawa, Noriko
    Young, Matthew R.
    Hegamyer, Glenn
    Baker, Alyson R.
    Santhanam, Arti N.
    Wei, Qiou
    Colburn, Nancy H.
    CANCER RESEARCH, 2011, 71
  • [33] The mechanisms and clinical significance of PDCD4 in colorectal cancer
    Long, Jiali
    Yin, Yuting
    Guo, Haina
    Li, Shuling
    Sun, Yanqin
    Zeng, Chao
    Zhu, Wei
    GENE, 2019, 680 : 59 - 64
  • [34] Pdcd4, a colon cancer prognostic that is regulated by a microRNA
    Allgayer, Heike
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 73 (03) : 185 - 191
  • [35] Alterations in the expression of PDCD4 in ductal carcinoma of the breast
    Wen, Yong Hannah
    Shi, Xiuquan
    Chiriboga, Luis
    Matsahash, Sachiko
    Yee, Herman
    Afonja, Olubunmi
    ONCOLOGY REPORTS, 2007, 18 (06) : 1387 - 1393
  • [36] Plk1 promotes Pdcd4 degradation to enhance enzalutamide resistance in prostate cancer
    Wang, Qing
    Zhang, Qiongsi
    Zhang, Yanquan
    Liu, Xiaoqi
    Yang, Hsin-Sheng
    CANCER RESEARCH, 2024, 84 (06)
  • [37] THE IMPORTANCE OF EXPRESSING PDCD4 AND PDCD5 ANTI-ONCOGENES IN GLIOMA
    Wang, C.
    Li, J. K.
    Li, H. Z.
    Gong, H. D.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (03): : 731 - 736
  • [38] Programmed cell death 4 (PDCD4) protein in esophageal cancer
    Fassan, M.
    Parente, P.
    Ruol, A.
    Pennelli, G.
    Rizzetto, C.
    Giacomelli, L.
    Lanza, C.
    Battaglia, G.
    Pizzi, M.
    Zaninotto, G.
    Ancona, E.
    Rugge, M.
    VIRCHOWS ARCHIV, 2009, 455 : 90 - 90
  • [39] SRSF3 represses the expression of PDCD4 protein by coordinated regulation of alternative splicing, export and translation
    Park, Seung Kuk
    Jeong, Sunjoo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (02) : 431 - 438
  • [40] Roles of PDCD4 and EIF4A1 in Breast Cancer
    Modelska, A.
    Le Quesne, J.
    Bottley, A.
    Osborne, M.
    Russell, R.
    Hadfield, J.
    Spriggs, K.
    Pharoah, P.
    Caldas, C.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S43 - S43
12345